165 related articles for article (PubMed ID: 28572734)
1. FOLFOX regimen plus dendritic cells-cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis.
Liu Y; Zheng Z; Zhang Q; Zhou X; Feng Y; Yan A
Onco Targets Ther; 2017; 10():2621-2633. PubMed ID: 28572734
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis.
Liu Y; Mu Y; Zhang A; Ren S; Wang W; Xie J; Zhang Y; Zhou C
Onco Targets Ther; 2017; 10():1897-1908. PubMed ID: 28408841
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of dendritic cells-cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis.
Zhang Y; Zhang X; Zhang A; Li K; Qu K
Onco Targets Ther; 2017; 10():4173-4192. PubMed ID: 28860827
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
Wang Y; Lv B; Li K; Zhang A; Liu H
Drug Des Devel Ther; 2017; 11():3245-3256. PubMed ID: 29180849
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis.
Yuan X; Zhang AZ; Ren YL; Wang XL; Jiang CH; Yang L; Liu CX; Liang WH; Pang LJ; Gu WY; Li F; Hu JM
Medicine (Baltimore); 2021 Apr; 100(13):e24519. PubMed ID: 33787569
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.
Lan XP; Chen YG; Wang Z; Yuan CW; Wang GG; Lu GL; Mao SW; Jin XB; Xia QH
J Zhejiang Univ Sci B; 2015 Sep; 16(9):743-56. PubMed ID: 26365116
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
Wang S; Wang Z
Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients.
Chen F; Yang M; Song Q; Wu J; Wang X; Zhou X; Yuan Y; Song Y; Jiang N; Zhao Y; Zhou L; Ren J
Mol Clin Oncol; 2017 Nov; 7(5):903-910. PubMed ID: 29181186
[TBL] [Abstract][Full Text] [Related]
15. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Sun YP; Wang YZ; Liu SY; Yu HS; Li CW; Zeng XT; Chen L; Yao XS; Feng JH
J Immunol Res; 2018; 2018():9081938. PubMed ID: 30648123
[TBL] [Abstract][Full Text] [Related]
16. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis.
Wang ZX; Cao JX; Wang M; Li D; Cui YX; Zhang XY; Liu JL; Li JL
Cytotherapy; 2014 Jul; 16(7):934-45. PubMed ID: 24794183
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer.
Sun J; Sun Y; Miniderima ; Wang X
Pathol Oncol Res; 2023; 29():1610710. PubMed ID: 37342361
[No Abstract] [Full Text] [Related]
18. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
[TBL] [Abstract][Full Text] [Related]
19. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Jiang N; Qiao G; Wang X; Morse MA; Gwin WR; Zhou L; Song Y; Zhao Y; Chen F; Zhou X; Huang L; Hobeika A; Yi X; Xia X; Guan Y; Song J; Ren J; Lyerly HK
Clin Cancer Res; 2017 Sep; 23(17):5066-5073. PubMed ID: 28611200
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.
Mu Y; Wang WH; Xie JP; Zhang YX; Yang YP; Zhou CH
Onco Targets Ther; 2016; 9():4617-27. PubMed ID: 27524915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]